In February 2015, Russia imported 35.2 bln RUR worth of ready-made pharmaceutical drugs, with the import expenditures rising by 22%, compared to 2014. The actual volume of import has fallen by 8.5% over the year, continuing the trend that started in January. As for the preferred currency, we can see the previous year’s trends returning – the percentage of contracts concluded in rubles has risen from 90% in January to 94% in February.

The prices have also risen considerably (+33.5%), compared to February 2014. Today, the average cost per unit of ready-made pharmaceutical drugs amounts to 204 RUR, with the average cost for VEDs exceeding 217 RUR. To a certain degree, that was the cause of a significant increase in the volume of import in ruble terms with a serious drop of the actual volume of import.

In February 2015, the import of packaged products skyrocketed, though. Compared to February 2014, the import expenditures have risen by as much as 53.5%. The actual volume of import also increases fast as it has risen by 21.5% since February 2014, and the volume of imported single-doses amounted to more than 275 mln.

Dynamics of Russian import of pharmaceutical drugs, CIP prices, RUR (January 2014 – February 2015)